These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 31765354)

  • 1. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
    Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
    Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese.
    Huang X; Xu M; Chen Y; Peng K; Huang Y; Wang P; Ding L; Lin L; Xu Y; Chen Y; Lu J; Wang W; Bi Y; Ning G
    Medicine (Baltimore); 2015 Oct; 94(40):e1682. PubMed ID: 26448014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.
    Sviklāne L; Olmane E; Dzērve Z; Kupčs K; Pīrāgs V; Sokolovska J
    J Gastroenterol Hepatol; 2018 Jan; 33(1):270-276. PubMed ID: 28464337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
    Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
    Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstructive sleep apnea is associated with fatty liver index, the index of nonalcoholic fatty liver disease.
    Chen X; Lin X; Chen LD; Lin QC; Chen GP; Yu YH; Huang JC; Zhao JM
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):650-5. PubMed ID: 26894633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.
    Zelber-Sagi S; Webb M; Assy N; Blendis L; Yeshua H; Leshno M; Ratziu V; Halpern Z; Oren R; Santo E
    World J Gastroenterol; 2013 Jan; 19(1):57-64. PubMed ID: 23326163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Fatty Liver Index for identifying non-alcoholic fatty liver disease in a Kenyan population.
    Lajeunesse-Trempe F; Boit MK; Kaduka LU; De Lucia-Rolfe E; Baass A; Paquette M; Piché ME; Tchernof A; Christensen DL
    Trop Med Int Health; 2023 Oct; 28(10):830-838. PubMed ID: 37650501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.
    Chen LW; Huang PR; Chien CH; Lin CL; Chien RN
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):173-181. PubMed ID: 30981560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study.
    Koehler EM; Schouten JN; Hansen BE; Hofman A; Stricker BH; Janssen HL
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1201-4. PubMed ID: 23353640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study.
    Zhu J; He M; Zhang Y; Li T; Liu Y; Xu Z; Chen W
    Endocr J; 2018 Mar; 65(3):373-381. PubMed ID: 29434074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.
    Wang C; Cai Z; Deng X; Li H; Zhao Z; Guo C; Zhang P; Li L; Gu T; Yang L; Zhao L; Wang D; Yuan G
    Int J Med Sci; 2021; 18(14):3280-3289. PubMed ID: 34400897
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatty liver index correlates with non-alcoholic fatty liver disease, but not with newly diagnosed coronary artery atherosclerotic disease in Chinese patients.
    Jiang ZY; Xu CY; Chang XX; Li WW; Sun LY; Yang XB; Yu LF
    BMC Gastroenterol; 2013 Jul; 13():110. PubMed ID: 23834773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Goulart AC; Oliveira IR; Alencar AP; Santos MS; Santos IS; Martines BM; Meireles DP; Martines JA; Misciagna G; Benseñor IM; Lotufo PA
    Sao Paulo Med J; 2015; 133(2):115-24. PubMed ID: 26018881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
    Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of visceral adiposity index with serum aminotransferase and nonalcoholic fatty liver disease in patients with sleep apnea].
    Qi J; Lin Q; Lin X; Chen X
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(42):3420-3. PubMed ID: 26813130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies].
    Nosov AE; Zenina MT; Gorbushina OY; Baidina AS; Vlasova EM; Alekseev VB
    Ter Arkh; 2021 Aug; 93(8):883-889. PubMed ID: 36286882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
    Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD.
    Chen J; Mao X; Deng M; Luo G
    Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):394-401. PubMed ID: 36695773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang.
    Guo Y; Hu Y; Yang J; Ma R; Zhang X; Guo H; Wang X; Li Y; Peng X; Zhang S; He J; Guo S
    Eur J Med Res; 2023 Dec; 28(1):555. PubMed ID: 38042816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.